Infantile progressive bulbar palsy: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Infantile progressive bulbar palsy | |||
| synonyms = [[Fazio-Londe disease]] | |||
| field = [[Neurology]] | |||
| symptoms = [[Dysphagia]], [[dysarthria]], [[facial weakness]], [[tongue atrophy]] | |||
| onset = [[Infancy]] | |||
| duration = [[Progressive]] | |||
| causes = [[Genetic mutation]] | |||
| risks = [[Family history]] | |||
| diagnosis = [[Clinical examination]], [[genetic testing]] | |||
| differential = [[Spinal muscular atrophy]], [[amyotrophic lateral sclerosis]] | |||
| treatment = [[Supportive care]], [[speech therapy]], [[nutritional support]] | |||
| prognosis = [[Variable]], often [[poor]] | |||
| frequency = [[Rare]] | |||
}} | |||
'''Infantile Progressive Bulbar Palsy''' (also known as '''Fazio-Londe disease''') is a rare, inherited, neurological disorder that primarily affects the [[bulbar muscles]] which control speech, swallowing, and breathing. The disease is characterized by progressive weakness and wasting (atrophy) of the muscles that control these functions. | '''Infantile Progressive Bulbar Palsy''' (also known as '''Fazio-Londe disease''') is a rare, inherited, neurological disorder that primarily affects the [[bulbar muscles]] which control speech, swallowing, and breathing. The disease is characterized by progressive weakness and wasting (atrophy) of the muscles that control these functions. | ||
== Symptoms == | == Symptoms == | ||
The symptoms of Infantile Progressive Bulbar Palsy typically appear in childhood, usually between the ages of 1 and 3. The most common symptoms include difficulty swallowing ([[dysphagia]]), slurred speech ([[dysarthria]]), and progressive weakness of the facial muscles. Other symptoms may include drooling, choking, and nasal regurgitation due to the weakness of the bulbar muscles. As the disease progresses, respiratory problems may develop, leading to frequent respiratory infections and eventually respiratory failure. | The symptoms of Infantile Progressive Bulbar Palsy typically appear in childhood, usually between the ages of 1 and 3. The most common symptoms include difficulty swallowing ([[dysphagia]]), slurred speech ([[dysarthria]]), and progressive weakness of the facial muscles. Other symptoms may include drooling, choking, and nasal regurgitation due to the weakness of the bulbar muscles. As the disease progresses, respiratory problems may develop, leading to frequent respiratory infections and eventually respiratory failure. | ||
== Causes == | == Causes == | ||
Infantile Progressive Bulbar Palsy is caused by mutations in the [[SMN1]] gene. This gene provides instructions for making a protein that is critical for the maintenance of [[motor neurons]], which are the nerve cells that control muscle movement. Mutations in the SMN1 gene lead to a decrease in the amount of this protein, which causes the motor neurons to deteriorate and die, leading to muscle weakness and atrophy. | Infantile Progressive Bulbar Palsy is caused by mutations in the [[SMN1]] gene. This gene provides instructions for making a protein that is critical for the maintenance of [[motor neurons]], which are the nerve cells that control muscle movement. Mutations in the SMN1 gene lead to a decrease in the amount of this protein, which causes the motor neurons to deteriorate and die, leading to muscle weakness and atrophy. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of Infantile Progressive Bulbar Palsy is based on the clinical symptoms, a detailed patient history, and specialized tests. These tests may include a [[nerve conduction study]] (NCS), [[electromyography]] (EMG), and genetic testing to identify mutations in the SMN1 gene. | Diagnosis of Infantile Progressive Bulbar Palsy is based on the clinical symptoms, a detailed patient history, and specialized tests. These tests may include a [[nerve conduction study]] (NCS), [[electromyography]] (EMG), and genetic testing to identify mutations in the SMN1 gene. | ||
== Treatment == | == Treatment == | ||
There is currently no cure for Infantile Progressive Bulbar Palsy. Treatment is symptomatic and supportive, and may include physical therapy, speech therapy, and nutritional support. Respiratory care is crucial due to the risk of respiratory failure. | There is currently no cure for Infantile Progressive Bulbar Palsy. Treatment is symptomatic and supportive, and may include physical therapy, speech therapy, and nutritional support. Respiratory care is crucial due to the risk of respiratory failure. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with Infantile Progressive Bulbar Palsy is generally poor, as the disease is progressive and can lead to life-threatening complications. However, the course of the disease can vary greatly from person to person. | The prognosis for individuals with Infantile Progressive Bulbar Palsy is generally poor, as the disease is progressive and can lead to life-threatening complications. However, the course of the disease can vary greatly from person to person. | ||
== See also == | == See also == | ||
* [[Spinal muscular atrophy]] | * [[Spinal muscular atrophy]] | ||
* [[Motor neuron disease]] | * [[Motor neuron disease]] | ||
* [[Bulbar palsy]] | * [[Bulbar palsy]] | ||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
Latest revision as of 01:31, 4 April 2025
| Infantile progressive bulbar palsy | |
|---|---|
| Synonyms | Fazio-Londe disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Dysphagia, dysarthria, facial weakness, tongue atrophy |
| Complications | N/A |
| Onset | Infancy |
| Duration | Progressive |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical examination, genetic testing |
| Differential diagnosis | Spinal muscular atrophy, amyotrophic lateral sclerosis |
| Prevention | N/A |
| Treatment | Supportive care, speech therapy, nutritional support |
| Medication | N/A |
| Prognosis | Variable, often poor |
| Frequency | Rare |
| Deaths | N/A |
Infantile Progressive Bulbar Palsy (also known as Fazio-Londe disease) is a rare, inherited, neurological disorder that primarily affects the bulbar muscles which control speech, swallowing, and breathing. The disease is characterized by progressive weakness and wasting (atrophy) of the muscles that control these functions.
Symptoms[edit]
The symptoms of Infantile Progressive Bulbar Palsy typically appear in childhood, usually between the ages of 1 and 3. The most common symptoms include difficulty swallowing (dysphagia), slurred speech (dysarthria), and progressive weakness of the facial muscles. Other symptoms may include drooling, choking, and nasal regurgitation due to the weakness of the bulbar muscles. As the disease progresses, respiratory problems may develop, leading to frequent respiratory infections and eventually respiratory failure.
Causes[edit]
Infantile Progressive Bulbar Palsy is caused by mutations in the SMN1 gene. This gene provides instructions for making a protein that is critical for the maintenance of motor neurons, which are the nerve cells that control muscle movement. Mutations in the SMN1 gene lead to a decrease in the amount of this protein, which causes the motor neurons to deteriorate and die, leading to muscle weakness and atrophy.
Diagnosis[edit]
Diagnosis of Infantile Progressive Bulbar Palsy is based on the clinical symptoms, a detailed patient history, and specialized tests. These tests may include a nerve conduction study (NCS), electromyography (EMG), and genetic testing to identify mutations in the SMN1 gene.
Treatment[edit]
There is currently no cure for Infantile Progressive Bulbar Palsy. Treatment is symptomatic and supportive, and may include physical therapy, speech therapy, and nutritional support. Respiratory care is crucial due to the risk of respiratory failure.
Prognosis[edit]
The prognosis for individuals with Infantile Progressive Bulbar Palsy is generally poor, as the disease is progressive and can lead to life-threatening complications. However, the course of the disease can vary greatly from person to person.
See also[edit]
